Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1
Gang She(Xi'an Jiaotong University), Yi Zhang(University of Southern California), Ru‐Yue Bai(Xi'an Jiaotong University), Zheng‐Da Pang(Xi'an Jiaotong University), Baochang Lai(Xi'an Jiaotong University), Meng-Zhuan Han(Xi'an Jiaotong University), Junichi Sadoshima(Rutgers, The State University of New Jersey), Jingjing Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Zhang(Nankai University), Yongjian Zhang(Xian Central Hospital), Yi-Yi Yang(Xi'an Jiaotong University), Xiao‐Jun Du(Xi'an Jiaotong University), Lihua Wu(First Affiliated Hospital Zhejiang University), Xiu‐Ling Deng(Ministry of Education), Xia-Xia Hai(Xi'an Jiaotong University), Yujie Ren(Wuhan Institute of Virology)
Cited by 23
Related Papers
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells
|Cellular and Molecular Immunology|2020|514
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387
Plasma metabolomic and lipidomic alterations associated with COVID-19
|National Science Review|2020|367